investorscraft@gmail.com

Intrinsic Value of Clovis Oncology, Inc. (CLVS)

Previous Close$0.00
Intrinsic Value
Upside potential
Previous Close
$0.00
* Our model cannot be used “out of the box” for the valuation of this stock. You can still do your own valuation by changing the valuation input parameters.

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2021-12-31 and quarterly data as of 2022-09-30.

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year(a)2022202320242025202620272028202920302031203220332034203520362037203820392040204120422043204420452046

INCOME STATEMENT

Revenue growth rate, %-9.6NaN
Revenue, $149NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m375NaN
Operating income, $m-226NaN
EBITDA, $m-215NaN
Interest expense (income), $mNaN
Earnings before tax, $m-265NaN
Tax expense, $m-0NaN
Net income, $m-265NaN

BALANCE SHEET

Cash and short-term investments, $m143NaN
Total assets, $m473NaN
Adjusted assets (=assets-cash), $m329NaN
Average production assets, $m135NaN
Working capital, $m73NaN
Total debt, $m619NaN
Total liabilities, $m752NaN
Total equity, $m-279NaN
Debt-to-equity ratio-2.219NaN
Adjusted equity ratio-1.246NaN

CASH FLOW

Net income, $m-265NaN
Depreciation, amort., depletion, $m11NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m-196NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-0NaN
Free cash flow, $m-196NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m73
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount